ORIGINAL RESEARCH ARTICLE
For active bacterial infection, recent research has focussed on the use of 2-stage total hip arthroplasty (THA), where antibiotic-loaded cement spacers or cement beads are implanted between stages. This technique has yielded positive results, with low failure rates from persistent infection and reinfection (7) (8) (9) (10) (11) (12) (13) (14) . However, there is variation in antibiotic and spacer use between studies. Single-stage THA has been used successfully for quiescent infection but has shown poor outcomes for the management of active infection, with most of the literature published in the 20 th century (9, (15) (16) (17) (18) . The aim of this study was to compare the outcomes of 2-stage and single-stage THA for active and quiescent infection of the native hip respectively, to a control series of patients treated for primary osteoarthritis (OA) of the hip. The null hypothesis was that the incidence of failure due to infection was higher following THA for SA than primary OA of the hip.
Methods

Study design
Between March 2000 and March 2013, 18 consecutive cases of SA of the hip treated with THA were identified retrospectively from a departmental registry at the Northern General Hospital, Sheffield. During the same period 18 controls of primary OA of the hip treated with THA were identified in the same manner. These 2 study groups were compared in a case-control study. 
Introduction
Septic arthritis (SA) of the native hip is a rare but challenging diagnosis. Active infection leads to destructive joint damage if untreated or diagnosed late (1) . Risk factors for septic arthritis include: intravenous drug use; hepatitis infection; and any cause of immunodeficiency (2) . The most common causative microorganism is Staphylococcus aureus, and diagnosis involves haematological, biochemical and histological investigation, as well as radiography (2, 3) .
Traditional management involved resection arthroplasty, for example, Girdlestone arthroplasty. Such management leads to poor functional outcomes, as well as high failure rates from infection (4, 5) . Conservative management with hip arthroscopy and intravenous antibiotics has been successful with non-bacterial uncomplicated infections only (6). We performed retrospective analysis of the prospectively collected data. The study received local departmental approval.
Eligibility criteria
Eligibility criteria for cases were determined by the diagnosis of SA of the hip, and similarly for controls by the diagnosis of primary OA of the hip. SA of the hip was diagnosed by clinical assessment, raised haematological inflammatory markers (white cell count, c-reactive protein and erythrocyte sedimentation rate), blood culture and joint aspiration. Active SA infection was specifically defined as a positive hip aspirate prior to the first stage of 2-stage THA.
Quiescent SA infection was defined by previous active SA of the hip treated with joint irrigation and debridement, with subsequent development of painful arthritis of the ipsilateral hip, and both negative hip aspiration and normal blood markers prior to subsequent single-stage THA. Some patients received their first stage of a 2-stage THA at a different hospital, but underwent their second stage at our centre. Primary OA of the hip was diagnosed by clinical and radiological assessment prior to THA.
Matching
Cases and controls were matched using frequency matching. Matching was conducted with regards to age, gender, body mass index (BMI), type of anaesthesia and American Society of Anesthesiologists (ASA) score. This method of matching ensured that each variable was similar between the case and control groups. The case group consisted of 11 cases of active SA infection treated with 2-stage THA, and 7 cases of quiescent SA infection treated with single stage THA (Tab. I).
Outcomes
Data were collected for the following outcomes: recurrence of infection, surgical re-revision for infection, aseptic prosthesis loosening and functional outcome at last follow-up appointment. Data regarding microbiology, radiology, time between operative stages and time between presentation and operation were also recorded.
All cases and controls were followed-up postoperatively at 6 weeks, 3 months, 6 months, and thereafter every 6 months. All cases and controls included were followed-up for at least 1 year. Each follow-up visit included clinical assessment, x-ray and haematology investigation. Functional outcome was determined narratively from the final follow-up clinic appointment notes and x-ray findings.
Operative details
Two-stage THA was performed through a posterior approach to the hip joint. Tissue samples were taken and sent to microbiology, and subsequently antibiotics were delivered parenterally. The choice of antibiotics was determined by microbiology advice from the culture and sensitivities of the preoperative hip aspirate. Total synovectomy with joint resection, and placement of antibiotic loaded cement beads in the acetabulum and femur medullary canal, was conducted (Fig. 1) . Cement beads were manually devised intraoperatively by the senior surgeon in each case using copal bone cement® mixed with 2 grams of vancomycin.
The same approach was used for the second stage. Further debridement and deep tissue samples were taken and sent to microbiology, followed by removal of the cement beads and implantation of the hip prosthesis (Fig. 2) . For single-stage THA for quiescent infection, a posterior approach 
Results
In the case group, the source of infection was haematogenous in 11 cases. 5 patients were intravenous drug users and 1 patient had septic arthritis of the hip as an adolescent following a complex proximal femoral osteotomy for dysplastic hip. In 1 case the source of infection was not clear from the records as they were referred from another hospital.
11 patients had positive hip aspiration for infection and 7 cases were negative in the case group. The microorganism identified by operative tissue sample or hip aspirate was Staphylococcus aureus in 11 cases, methicillin-resistant Staphylococcus aureus in 1 case, Streptococcus in 1 case and polymicrobial in 2 cases. The causative microorganism could not be identified in 3 cases of quiescent SA infection as the previous active hip infection was treated at a different hospital. Table II summarises the operative and outcome data for each study group. For the active cases treated with 2-stage THA, the mean time between operative stages was 4 months (range 3-5 months). For the quiescent cases treated with single stage THA the mean time from presentation of sepsis and single-stage THA was 4 years (range 2-10 years).
The case and control groups were followed-up for a mean period of 70 and 72 weeks respectively. 1 patient in the case group was lost to follow-up at 14 months following surgery due to them moving away from the region. They were an intravenous drug user treated with 2-stage THA for active SA infection, and had no documented complication at the last follow-up.
There was 1 case of prosthetic hip joint infection occurring in the control group. The patient developed septicaemia and was not fit to have any form of revision surgery. The causative microorganism in this case was haematogenous Staphylococcus aureus. No other cases showed signs of infection on clinical, biochemical or radiology investigation. In the case group, one patient developed ipsilateral hip dislocation 8 weeks post-surgery. This was relocated in theatre and subsequently there were no further complications.
Two cases and three controls developed heterotrophic ossification following prosthesis fixation. According to Brooker Data presented as mean (minimum -maximum) and count (proportion).
was also taken. Tissue samples were taken and sent to microbiology prior to the implantation of the hip prosthesis. Single-stage THA for primary OA was a standard elective procedure, undertaken through posterior approach to the hip joint. A single dose of prophylactic parenteral antibiotics was given preoperatively. The choice of antibiotics was governed by local microbiology policy.
In each operation where tissue samples were taken, a minimum of 6 tissue samples were collected. The type of prosthesis, as well as whether it was implanted with or without bone cement, varied between cases and controls. The operations were conducted by the senior authors (A.H., S.B., I.S.).
Statistical methods
Demographic and outcome data were compared between cases and controls using chi-square tests of independence and independent-samples t-tests. All analysis was conducted using SPSS version 20. grading, 4 were grade 1 and 1 was grade 2. Functional outcomes, in terms of mobility and activities of daily living (ADL), were similar in both groups following THR.
Discussion
The aim of this study was satisfied, with outcomes from THA compared between those with SA and primary OA of the hip. The results disagree with the null hypothesis, as they show the incidence of failure due to infection following THA was similar between those with SA (cases) and primary OA (controls) of the hip. Furthermore, this is the 1 st case-control study of THA for septic arthritis of the hip, as can be determined.
There are many studies detailing the successful outcomes of THA for SA of the hip. Such research has shown that THA in comparison to resection arthroplasty leads to better functional outcomes and infection resolution. However, there is still variation in the procedure of THA for SA of the hip. Table III shows that there are many studies examining the outcomes of 2-stage THA for active SA hip infection. Apart from this study, they are all cohort studies. The table shows that those with a shorter time between stages may possibly have a higher rate of postoperative infection (8, 9, 11) . However, other studies examining revision hip arthroplasty for infection have found time between stages has no effect on reinfection rate (19) . The results of this study are comparable to others published, with a longer follow-up time and low reinfection rate.
During 2-stage THA for SA of the hip some studies have utilised preformed spacers between stages (7, 8, 10, 14) , whilst others have used cement spacers (9, 12, 13) or cement beads (13). Diwanji et al reported better outcomes for 2-stage THA using cement spacers rather than cement beads (13) . However, studies of periprosthetic infections of the hip have found that cement beads as part of 2-stage THA yield successful outcomes (20, 21) , though 1 study found better functional outcomes in the period between stages for those with cement spacers over cement beads (22) .
The use of postoperative antibiotics also varies; with postoperative treatment regimens ranging from 3 (10, 13) to 120 (9) days, and given intravenously, orally or a combination of both. However, most use an intravenous regimen of 4 to 6 weeks (7, 8, 11, 12, 14) , providing a strong evidence base for future postoperative antibiotic use following THA for SA of the hip. The use of cement or cementless prostheses varies. Some studies used antibiotic impregnated cement to fix the hip prosthesis (11), whilst others used cementless prostheses (7, 10, 11, 13) . However, this nuance is in fact largely unreported in the studies, and this study reports a mix of cemented and uncemented prosthesis. The effect of this variability is unclear, though arguably leaving antibioticimpregnated cement in-situ would be the safer option for preventing reinfection.
For revision THA, 2-stage arthroplasty is known to result in lower infection rates than single stage arthroplasty. However, single-stage arthroplasty results in less surgical related morbidity, and better patient satisfaction due to fewer operations (23) . Therefore, where appropriate it is beneficial to conduct a single stage procedure. Treatment of quiescent SA infection of the hip with single stage THA has shown to be sufficient in improving functional outcomes with minimal adverse outcomes, such as failure and infection (Tab. IV). Table IV shows that the results from this study compare favourably to others published. Studies with larger sample sizes have identified higher reinfection rates; however, they are older studies with larger durations between presentation and operation (15, 16, 18) . However, Kim et al (18) provides the largest and newest study of the operative technique, identifying a low reinfection rate of 1.2% (2/170).
This study is limited by a small sample size, which is due to the low incidence of SA of the hip. It is further limited by the absence of reporting outcomes between stages during 2-stage THA, and reporting functional outcome without the use of hip scores.
Conclusion
In our study, 2-stage and single-stage THA for active and quiescent SA infection respectively of the hip have shown similar outcomes to total hip arthroplasty for primary OA of the hip. These results are comparable to other published data, though this is the first study to utilise a case-control methodology.
